Currently out of the existing stock ratings of Kevin Strang, 2 are a BUY (100%).

Kevin Strang

Work Performance Price Targets & Ratings Chart

Analyst Kevin Strang, currently employed at JEFFERIES,

Kevin Strang has documented 4 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PRAX, Praxis Precision Medicines at 20-Aug-2026.

Wall Street Analyst Kevin Strang

Analyst best performing recommendations are on PRAX (PRAXIS PRECISION MEDICINES).
PRAX Praxis Precision Medicines

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Apr-2024

$568

$257.73 (83.07%)

$400

1 days ago
(15-Nov-2026)

Buy Since 17-Jun-2024

$1050

$739.73 (238.41%)

$800

1 days ago
(15-Nov-2026)

Sell Since 04-May-2025

$189

$-121.27 (-39.09%)

$162

7 days ago
(09-Nov-2026)

7/21 (33.33%)

$-148.59 (-44.01%)

91

Hold Since 01-Feb-2026

$343

$32.73 (10.55%)

$362

7 days ago
(09-Nov-2026)

4/4 (100%)

$5.41 (1.60%)

20

Buy Since 17-Jun-2026

$478

$167.73 (54.06%)

$462

7 days ago
(09-Nov-2026)

0/3 (0%)

$140.41 (41.59%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Kevin Strang most bullish on?

Potential upside of $264.73 has been obtained for PRAX (PRAXIS PRECISION MEDICINES)

What Year was the first public recommendation made by Kevin Strang?

On 2026
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?